Reata Pharmaceuticals Inc

FMR LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

305,225

Value ($000)

31,121

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	31,121	0.0%	305,225	6/30/2023
2023 Q1	5/11/2023	11,318	0.0%	124,485	3/31/2023
2022 Q4	2/13/2023	14,591	0.0%	384,076	12/31/2022
2022 Q3	11/10/2022	12,964	0.0%	515,881	9/30/2022
2022 Q2	8/12/2022	16,093	0.0%	529,550	6/30/2022
2022 Q1	5/13/2022	13,584	0.0%	414,661	3/31/2022
2021 Q4	2/14/2022	6,082	0.0%	230,640	12/31/2021
2021 Q3	2/14/2022	82,265	0.0%	817,665	9/30/2021
2021 Q2	8/13/2021	106,139	0.0%	749,933	6/30/2021
2021 Q1	5/14/2021	6,075	0.0%	60,932	3/31/2021
2020 Q4	2/8/2021	59,960	0.0%	485,032	12/31/2020
2020 Q3	11/13/2020	47,971	0.0%	492,416	9/30/2020
2020 Q2	8/24/2020	135,246	0.0%	866,848	6/30/2020
2020 Q1	5/14/2020	104,845	0.0%	726,370	3/31/2020
2019 Q4	2/7/2020	73,384	0.0%	358,968	12/31/2019